Effect of microRNA-21 on Proliferation and Apoptosis of Osteosarcoma Cells via Phosphatase and Tensin Homologue (PTEN)-Phosphoinositide 3-Kinase (PI3K)/AKT Pathway

被引:0
作者
Huang, Lei [1 ]
Xie, Yongheng [1 ]
Yao, Zilong [1 ]
Yu, Bin [1 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou 510515, Guangdong, Peoples R China
关键词
microRNA-21; PTEN; PI3K/AKT; Osteosarcoma; CANCER CELLS; PROMOTES; MIR-21; EXPRESSION; BIOMARKER; PROGNOSIS; INVASION;
D O I
10.1166/jbt.2020.2293
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Objective: PTEN can inhibit the activity of PI3K/AKT signaling and regulate cell proliferation and apoptosis. Increased expression of microRNA-21 is associated with osteosarcoma. Bioinformatics analysis showed a targeted binding site between microRNA-21 and PTEN 3'-UTR. Our study assessed whether microRNA-21 regulates PTEN-PI3K/AKT signaling and affects the proliferation, cloning and apoptosis of osteosarcoma cells. Methods: Dual luciferase reporter gene assay was used to assess the targeted interaction between microRNA-21 and PTEN. Expression of microRNA21 and PTEN was measured in human normal osteoblasts hFOB1.19, osteosarcoma Saos-2 and MG-63. Saos-2 cells were cultured and divided into microRNA-NC group and microRNA-21 inhibitor group followed by measuring the expression of microRNA-21, PTEN and p-AKT, cell apoptosis by flow cytometry, cell proliferation by EdU staining and cloning ability by plate cloning. Results: There was a targeted relationship between microRNA-21 and PTEN. Compared with hFOB1.19 cells, microRNA-21 level in Saos-2 and MG-63 cells was increased and PTEN was decreased. Transfection of microRNA-21 inhibitor significantly reduced microRNA-21 level in Saos-2 cells, increased PTEN, decreased p-AKT, cell proliferation and cloning ability, as well as promoted cell apoptosis. Conclusion: The increased microRNA-21 expression may play a role in reducing PTEN level and promoting osteosarcoma pathogenesis. Inhibiting microRNA-21 can inhibit the activity of PTEN-PI3K/AKT signaling, reduce the proliferation and cloning ability of osteosarcoma cells, and promote cell apoptosis.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 23 条
[1]  
Hua Y, 2017, EUR REV MED PHARMACO, V21, P2989
[2]  
Jiang JH, 2018, EUR REV MED PHARMACO, V22, P6260, DOI 10.26355/eurrev_201810_16033
[3]  
Khalighfard S., SCI REP, V8, P17981
[4]   MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway [J].
Li, Lihua ;
Zhu, Xiongjie ;
Shou, Tao ;
Yang, Libo ;
Cheng, Xiaozhen ;
Wang, Jinting ;
Deng, Lian ;
Zheng, Yanfang .
MOLECULAR MEDICINE REPORTS, 2018, 17 (03) :4003-4010
[5]   MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7 [J].
Li, Xiangpan ;
Wu, Xiaofei .
ONCOTARGETS AND THERAPY, 2018, 11 :8445-8454
[6]   Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma [J].
Nakka, Manjula ;
Allen-Rhoades, Wendy ;
Li, Yiting ;
Kelly, Aaron J. ;
Shen, Jianhe ;
Taylor, Aaron M. ;
Barkauskas, Donald A. ;
Yustein, Jason T. ;
Andrulis, Irene L. ;
Wunder, Jay S. ;
Gorlick, Richard ;
Meltzer, Paul S. ;
Lau, Ching C. ;
Man, Tsz-Kwong .
ONCOTARGET, 2017, 8 (57) :96738-96752
[7]   A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma [J].
Ouyang, Liu ;
Liu, Ping ;
Yang, Shuhua ;
Ye, Shunan ;
Xu, Weihua ;
Liu, Xianzhe .
MEDICAL ONCOLOGY, 2013, 30 (01)
[8]  
Qiu YF, 2018, EUR REV MED PHARMACO, V22, P7735, DOI 10.26355/eurrev_201811_16395
[9]   miR-21 predicts poor prognosis in patients with osteosarcoma [J].
Ren, Xianfeng ;
Shen, Yuqin ;
Zheng, Shuyun ;
Liu, JianYong ;
Jiang, Xin .
BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2016, 73 (04) :158-162
[10]  
Wang N, 2018, EUR REV MED PHARMACO, V22, P7653, DOI 10.26355/eurrev_201811_16382